Do Environmental Estrogens Contribute to the Decline in Male Reproductive Health?
Tina Kold Jensen,"4 Jorma Toppari,2 Niels Keiding,3 and Niels Enk Skakkebaek' Several observations suggest that male reproductive health has been declining since World War II in many countries.
The incidence of testicular cancer, hypospadias, and cryptorchidism has been increasing and semen quality has been decreasing, and these may have a common etiology. Treatment of several million pregnant women with the synthetic estrogen diethylstilbestrol led to an increase in these conditions among the sons of these women. These abnormalities probably arise during fetal development.
The similarity between these effects and the adverse change in male reproductive development and function raised the question of whether the adverse changes are attributable to altered exposures to estrogenic and other endocrine-disrupting agents during fetal development.
We speculate that alteration in exposure to estrogen in the past half-century may have caused the changes in male reproductive health.
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Several observations suggest that male reproductive health has been declining since World War II in many countries.
The incidence of testicular cancer, hypospadias, and probably cryptorchidism has been increasing, and semen quality has been decreasing.
Because these changes have occurred over a short time span, we presume that they reflect adverse effects of environmental or life-style factors rather than genetic changes. All of these abnormalities probably arise during fetal development and may have a common etiology.
Between 1945 and 1971, treatment of several million pregnant women with the synthetic estrogen diethylstilbestrol (DES) led to an increase in the incidence of cryptorchidism, hypospadias, and decreased sperm count in the sons of these women.
The similarity between these effects and the adverse change in male reproductive development and function raised the question of whether the adverse changes are attributable to altered exposures to estrogenic and other endocrine-disrupting agents during fetal development. with a decrease as well as with no change or an increase in semen quality, the general conclusion was that an overall decline occurred during the 50-year period (9). The findings of Carlsen et al. were also compared with the 1979 data of MacLeod and Wang from the US (6). This comparison is not relevant, however, because the metaanalysis was based on semen analyses of apparently fertile men, whereas the American study examined infertility clients. One limitation of metaanalysis is that data are procured from several studies performed under inconsistent conditions. Now three studies have been performed on donors from the same laboratories.
A French study of 1351 healthy men volunteering for sperm donation reported a decrease of 2.1% in sperm concentration per year, from 89 X i09fL in 1973 to 60 x i0#{176}fL in 1992 (10) (Fig. 2) . The percentages of motile and normal spermatozoa also decreased substantially, whereas sperm volume remained unchanged (3.8 X l0 L). The year of birth of the subjects in the studies contributed considerably to the results. Similar results were obtained in a Scottish study of several hundred selected semen donors (11) with sperm counts >20 x 1091L who provided 3729 semen samples from 1940 to 1969. Semen concentration decreased from 120 to 75 X lO9fL, and median sperm count was related to year of birth. A smaller Belgian study of donor candidates over the past two decades also reported decreased sperm count and motility (12). Data from the above-mentioned studies were from individual laboratories that used the same methods consistently for semen analysis throughout the period.
The association between declining semen quality and increasing year of birth supports the concept that adverse prenatal factorsmay influence the sperm production capacity in adult life.
The decrease in semen quality may not be global, since the sperm concentration of Finnish men has remained unchanged from 1958 to 1992 (111 x i09/L vs 124 x 109/L) and is higher than elsewhere in Europe (5). The incidence of testicular cancer in Finland is much lower than in the other Nordic countries, suggesting that these two phenomena may be related in some way.
Trends inIncidence of TesticularCancer
Testicular cancer is now the most common malignancy of young men in many countries; although it is still rare compared with the malignant diseases most prevalent in old age, the lifetime risk of developing testicular cancer now approaches 1% in Denmark. The incidence of testicular cancer has been increasing for several decades (13). On the basis of data from several cancer registries, increases in incidence are evident in England and Wales (14) , Scotland (15) , the Nordic and Baltic countries (16), Australia (17), New Zealand (18) , and the US (19). The observed increase has been 2-4% per annum in men younger than age 50 ( Fig. 3 ) (13) and has occurred in those between ages 20 and 45 years, in whom the incidence of testicular cancer is highest (Fig. 4 ). Marked differences in race and in geographical areas exist; e.g., the incidence in Denmark is fourfold higher than in Finland, and whites are threefold more susceptible tothis disease than are blacks in the US. We do not know the etiology of testicular cancer and therefore cannot prevent the disease. Gill et al. (42) studied semen samples from 88 men exposed to DES and 85 men exposed to placebo who were offspring of the Dieckmann cohort. Sperm concentration was much lower among men exposed to DES. There was no difference in semen volume, whereas the total sperm count, the sperm motility grade, the total number of motile sperm, the percentage of sperm with normal morphology, and the quality score were all statistically lower in men exposed to DES. In a later study of the same men, only semen concentration differed in the two groups (39). Similar findings were reported in another study including 17 men exposed to DES and 12 controlsubjects(46). However, Andonian and Kessler (47) found no difference in semen quality between 24 men exposed to DES and 24 age-matched control subjects.
Not enough evidence exists to indicate an increased risk of testicular cancer in men exposed to DES (19, [48] [49] [50] [51] [52] [53] , but the case-control studies thus far performed include major design problems.
Hormone treatment may have been initiated at variable times during pregnancy; therefore, the presumed critical period when adverse effectsof estrogens might occur may have been missed in some of these studies.
Furthermore, the exact prescribed hormone and the dose are often not remembered and therefore some women may have been treated with only progesterone. Also, the number of cases has been too small to determine whether a substantial difference truly exists, and recall bias may also be present.
Estrogen Hypothesis
The similarities between the effects caused by DES exposure;
the Australia (1950 Australia ( -1985 
